107 related articles for article (PubMed ID: 19881539)
1. Chromosomal rearrangements after ex vivo Epstein-Barr virus (EBV) infection of human B cells.
Lacoste S; Wiechec E; Dos Santos Silva AG; Guffei A; Williams G; Lowbeer M; Benedek K; Henriksson M; Klein G; Mai S
Oncogene; 2010 Jan; 29(4):503-15. PubMed ID: 19881539
[TBL] [Abstract][Full Text] [Related]
2. Steps involved in immortalization and tumorigenesis in human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
Sugimoto M; Tahara H; Ide T; Furuichi Y
Cancer Res; 2004 May; 64(10):3361-4. PubMed ID: 15150084
[TBL] [Abstract][Full Text] [Related]
3. The cytogenetics of human B lymphoid malignancy: studies in Burkitt's lymphoma and Epstein-Barr virus-transformed lymphoblastoid cell lines.
Steel CM; Morten JE; Foster E
IARC Sci Publ; 1985; (60):265-92. PubMed ID: 2998993
[TBL] [Abstract][Full Text] [Related]
4. Copy number increase of 1p36.33 and mitochondrial genome amplification in Epstein-Barr virus-transformed lymphoblastoid cell lines.
Jeon JP; Shim SM; Nam HY; Baik SY; Kim JW; Han BG
Cancer Genet Cytogenet; 2007 Mar; 173(2):122-30. PubMed ID: 17321327
[TBL] [Abstract][Full Text] [Related]
5. Expression of P2 receptors in human B cells and Epstein-Barr virus-transformed lymphoblastoid cell lines.
Lee DH; Park KS; Kong ID; Kim JW; Han BG
BMC Immunol; 2006 Sep; 7():22. PubMed ID: 16970829
[TBL] [Abstract][Full Text] [Related]
6. Regulation and dysregulation of Epstein-Barr virus latency: implications for the development of autoimmune diseases.
Niller HH; Wolf H; Minarovits J
Autoimmunity; 2008 May; 41(4):298-328. PubMed ID: 18432410
[TBL] [Abstract][Full Text] [Related]
7. Efficient gene delivery into epstein-barr virus (EBV)-transformed human B cells mediated by replication-defective herpes simplex virus-1 (HSV-1): A gene therapy model for EBV-related B cell malignancy.
Suzuki T; Piche A; Kasono K; Xiang J; Gomez-Navarro J; Moriuchi S; Krisky DM; Oligino T; Glorioso JC; Curiel TJ; Curiel DT
Biochem Biophys Res Commun; 1998 Nov; 252(3):686-90. PubMed ID: 9837767
[TBL] [Abstract][Full Text] [Related]
8. EBV transformation overrides gene expression patterns of B cell differentiation stages.
Siemer D; Kurth J; Lang S; Lehnerdt G; Stanelle J; Küppers R
Mol Immunol; 2008 Jun; 45(11):3133-41. PubMed ID: 18430472
[TBL] [Abstract][Full Text] [Related]
9. Identification of tumor necrosis factor signaling-related proteins during Epstein-Barr virus-induced B cell transformation.
Jeon JP; Kim JW; Park B; Nam HY; Shim SM; Lee MH; Han BG
Acta Virol; 2008; 52(3):151-9. PubMed ID: 18999889
[TBL] [Abstract][Full Text] [Related]
10. Abnormal telomere dynamics of B-lymphoblastoid cell strains from Werner's syndrome patients transformed by Epstein-Barr virus.
Tahara H; Tokutake Y; Maeda S; Kataoka H; Watanabe T; Satoh M; Matsumoto T; Sugawara M; Ide T; Goto M; Furuichi Y; Sugimoto M
Oncogene; 1997 Oct; 15(16):1911-20. PubMed ID: 9365237
[TBL] [Abstract][Full Text] [Related]
11. Lack of pseudotype formation between human immunodeficiency virus type 1 and Epstein-Barr virus in productively coinfected B lymphoblastoid cell lines.
Van Kuyk R; Mosier DE
Virology; 1995 Jun; 209(2):643-8. PubMed ID: 7778296
[TBL] [Abstract][Full Text] [Related]
12. Selective efficacy of depsipeptide in a xenograft model of Epstein-Barr virus-positive lymphoproliferative disorder.
Roychowdhury S; Baiocchi RA; Vourganti S; Bhatt D; Blaser BW; Freud AG; Chou J; Chen CS; Xiao JJ; Parthun M; Chan KK; Eisenbeis CF; Ferketich AK; Grever MR; Chen CS; Caligiuri MA
J Natl Cancer Inst; 2004 Oct; 96(19):1447-57. PubMed ID: 15467034
[TBL] [Abstract][Full Text] [Related]
13. Clonal chromosomal aberrations accompanied by strong telomerase activity in immortalization of human B-lymphoblastoid cell lines transformed by Epstein-Barr virus.
Okubo M; Tsurukubo Y; Higaki T; Kawabe T; Goto M; Murase T; Ide T; Furuichi Y; Sugimoto M
Cancer Genet Cytogenet; 2001 Aug; 129(1):30-4. PubMed ID: 11520562
[TBL] [Abstract][Full Text] [Related]
14. Growth and spread in nude mice of Epstein-Barr virus transformed B-cells from a chronic lymphocytic leukemia patient.
Lee CL; Uniyal S; Fernandez LA; Lee SH; Ghose T
Cancer Res; 1986 May; 46(5):2497-501. PubMed ID: 3008990
[TBL] [Abstract][Full Text] [Related]
15. Identification and characterization of an Epstein-Barr virus-specific T-cell response in the pathologic tissue of a patient with Hodgkin's disease.
Dolcetti R; Frisan T; Sjöberg J; De Campos-Lima PO; Pisa P; De Re V; Gloghini A; Rizzo S; Masucci MG; Boiocchi M
Cancer Res; 1995 Aug; 55(16):3675-81. PubMed ID: 7627978
[TBL] [Abstract][Full Text] [Related]
16. Epstein-Barr virus (EBV)-encoded RNA 2 (EBER2) but not EBER1 plays a critical role in EBV-induced B-cell growth transformation.
Wu Y; Maruo S; Yajima M; Kanda T; Takada K
J Virol; 2007 Oct; 81(20):11236-45. PubMed ID: 17686859
[TBL] [Abstract][Full Text] [Related]
17. Whole chromosome loss is promoted by telomere dysfunction in primary cells.
Pampalona J; Soler D; Genescà A; Tusell L
Genes Chromosomes Cancer; 2010 Apr; 49(4):368-78. PubMed ID: 20088004
[TBL] [Abstract][Full Text] [Related]
18. Immune activation suppresses initiation of lytic Epstein-Barr virus infection.
Ladell K; Dorner M; Zauner L; Berger C; Zucol F; Bernasconi M; Niggli FK; Speck RF; Nadal D
Cell Microbiol; 2007 Aug; 9(8):2055-69. PubMed ID: 17419714
[TBL] [Abstract][Full Text] [Related]
19. Immortalization of Epstein-Barr virus-negative human B lymphocytes with minimal chromosomal instability.
Yamashita Y; Tsurumi T; Mori N; Kiyono T
Pathol Int; 2006 Nov; 56(11):659-67. PubMed ID: 17040288
[TBL] [Abstract][Full Text] [Related]
20. Distinct profiles of critically short telomeres are a key determinant of different chromosome aberrations in immortalized human cells: whole-genome evidence from multiple cell lines.
Deng W; Tsao SW; Guan XY; Lucas JN; Si HX; Leung CS; Mak P; Wang LD; Cheung AL
Oncogene; 2004 Dec; 23(56):9090-101. PubMed ID: 15489894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
